Back to Iowa

HF2010 • 2026

A bill for an act relating to the advertising of prescription drugs and vaccines and providing civil penalties.

A bill for an act relating to the advertising of prescription drugs and vaccines and providing civil penalties.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
GEARHART
Last action
2026-01-13
Official status
Introduced, referred to Health and Human Services. H.J. 42 .
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

A bill for an act relating to the advertising of prescription drugs and vaccines and providing civil penalties.

A bill for an act relating to the advertising of prescription drugs and vaccines and providing civil penalties.

What This Bill Does

  • A bill for an act relating to the advertising of prescription drugs and vaccines and providing civil penalties.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-01-13 Iowa Legislature

    Introduced, referred to Health and Human Services. H.J. 42 .

Official Summary Text

A bill for an act relating to the advertising of prescription drugs and vaccines and providing civil penalties.

Current Bill Text

Read the full stored bill text
House

File

2010

-

Introduced

HOUSE

FILE

2010

BY

GEARHART

A

BILL

FOR

An

Act

relating

to

the

advertising

of

prescription

drugs

and

1

vaccines

and

providing

civil

penalties.

2

BE

IT

ENACTED

BY

THE

GENERAL

ASSEMBLY

OF

THE

STATE

OF

IOWA:

3

TLSB

5037YH

(3)

91

ak/jh

H.F.

2010

Section

1.

SHORT

TITLE.

This

Act

shall

be

known

and

may

be

1

cited

as

the

“Iowa

Pharmaceutical

Advertising

Transparency

and

2

Consumer

Protection

Act”.

3

Sec.

2.

NEW

SECTION

.

714.30

Pharmaceutical

advertising

——

4

restrictions.

5

1.

As

used

in

this

section,

unless

the

context

otherwise

6

requires:

7

a.

“Government-sponsored”

means

funded

in

whole

or

in

part

8

by

a

federal,

state,

local

government,

or

an

agency

thereof.

9

b.

“Pharmaceutical

company”

means

any

entity

that

10

manufactures,

markets,

distributes,

or

sells

prescription

11

drugs.

12

c.

“Prescription

drug”

means

the

same

as

defined

in

section

13

155A.3.

14

d.

“Television

advertisement”

means

any

video-based

15

advertisement

promoting

a

prescription

drug

or

vaccine,

16

broadcast

via

traditional

television

or

a

digital

streaming

17

platform.

18

2.

Beginning

January

1,

2027,

any

pharmaceutical

19

company-sponsored

television

advertisement

aired

in

this

state

20

must

comply

with

all

of

following:

21

a.

Clearly

and

audibly

state

the

average

retail

price

for

22

a

standard

thirty-day

supply

or

the

cost

of

a

full

course

of

23

treatment,

whichever

is

higher.

24

b.

Disclose

all

known

common

and

serious

side

effects

and

25

contraindications

associated

with

the

prescription

drug

or

26

vaccine,

in

plain

and

understandable

language

with

equal

visual

27

and

auditory

prominence.

28

c.

Not

be

aired

for

any

prescription

drug

until

at

least

29

twelve

months

have

passed

since

the

date

of

initial

approval

by

30

the

federal

food

and

drug

administration.

31

3.

Beginning

January

1,

2027,

any

government-sponsored

32

television

advertisement

aired

in

this

state

must

disclose

all

33

known

common

and

serious

side

effects

and

contraindications

34

associated

with

the

prescription

drug

or

vaccine,

in

35

-1-

LSB

5037YH

(3)

91

ak/jh

1/

4

H.F.

2010

plain

and

understandable

language,

with

equal

visual

and

1

auditory

prominence.

This

requirement

applies

to

any

2

government-sponsored

television

advertisement

of

prescription

3

drugs

or

vaccines,

regardless

of

the

pharmaceutical

company

4

that

manufactures

the

prescription

drug

or

vaccine.

5

4.

A

violation

of

this

section

constitutes

an

unlawful

6

practice

pursuant

to

section

714.16,

and

the

attorney

general

7

has

all

the

powers

enumerated

in

that

section

to

enforce

the

8

provisions

of

this

section,

unless

otherwise

stated

in

this

9

section.

In

enforcing

the

provisions

of

this

section,

the

10

attorney

general

may

do

any

of

the

following:

11

a.

Notwithstanding

section

714.16,

subsection

7,

seek

an

12

assessment

by

a

district

court

of

civil

fines

not

exceeding

13

fifty

thousand

dollars

per

violation.

In

the

case

of

a

14

continuing

violation,

each

day

of

the

continuing

violation

15

constitutes

a

separate

violation.

16

b.

Request

that

a

district

court

order

a

cease

and

desist

or

17

other

injunctive

relief

as

appropriate.

18

c.

Publicly

disclose

violative

conduct

for

consumer

19

awareness

via

notice

or

post

on

the

attorney

general’s

internet

20

site.

21

5.

An

enforcement

action

taken

pursuant

to

this

section

22

shall

be

in

accordance

with

due

process

of

law

and

subject

to

23

appeal

to

the

district

court

pursuant

to

sections

17A.19

and

24

17A.20.

25

6.

The

attorney

general

may

adopt

rules

pursuant

to

chapter

26

17A

as

necessary

or

appropriate

to

implement

the

purposes

of

27

this

section.

28

7.

Any

moneys

collected

under

this

section,

including

29

civil

penalties,

costs,

attorney

fees,

or

amounts

which

30

are

specifically

directed,

shall

be

paid

into

the

consumer

31

education

and

litigation

fund

established

under

section

32

714.16C.

33

EXPLANATION

34

The

inclusion

of

this

explanation

does

not

constitute

agreement

with

35

-2-

LSB

5037YH

(3)

91

ak/jh

2/

4

H.F.

2010

the

explanation’s

substance

by

the

members

of

the

general

assembly.

1

This

bill

creates

the

Iowa

pharmaceutical

advertising

2

transparency

and

consumer

protection

Act

in

new

Code

section

3

714.30,

and

provides

for

civil

penalties.

4

The

bill

provides

definitions

used

in

the

new

Code

section

5

including

“pharmaceutical

company”,

“television

advertisement”,

6

“prescription

drug”,

and

“government-sponsored”.

7

The

bill

provides

that,

beginning

on

January

1,

2027,

8

pharmaceutical

companies

are

prohibited

from

airing

on

9

television

in

Iowa

any

advertisement

for

prescription

drugs

or

10

vaccines

without

clearly

and

audibly

stating

the

highest

of

11

either

the

average

retail

price

for

a

standard

30-day

supply

12

or

the

cost

of

a

full

course

of

treatment.

Additionally,

13

pharmaceutical

companies

in

these

television

advertisements

14

must

disclose

all

known

common

and

serious

side

effects

and

15

contraindications

associated

with

the

prescription

drug

or

16

vaccine,

in

plain

and

understandable

language,

with

equal

17

visual

and

auditory

prominence.

The

bill

also

prohibits

18

pharmaceutical

companies

from

advertising

on

television

any

19

prescription

drug

until

one

year

after

its

approval

by

the

20

federal

food

and

drug

administration.

21

The

bill

further

provides

that,

beginning

on

January

1,

22

2027,

any

government-sponsored

television

advertisement

for

23

prescription

drugs

or

vaccines

aired

in

Iowa

must

disclose

all

24

known

common

and

serious

side

effects

and

contraindications

25

associated

with

the

prescription

drug

or

vaccine.

The

bill

26

specifies

that

this

disclosure

is

required

regardless

of

27

the

pharmaceutical

company

manufacturing

the

advertised

28

prescription

drug

or

vaccine.

29

A

violation

of

the

bill

constitutes

an

unlawful

practice

30

under

Code

section

714.16,

the

Iowa

consumer

fraud

Act,

which

31

allows

the

attorney

general

to

investigate,

issue

subpoenas,

32

recover

costs

of

court

action

and

any

investigations,

and

33

commence

civil

proceedings

against

a

person

found

to

have

34

committed

an

unlawful

practice.

The

bill

authorizes

the

35

-3-

LSB

5037YH

(3)

91

ak/jh

3/

4

H.F.

2010

attorney

general

to

enforce

the

new

Code

section

using

the

1

same

powers

authorized

under

the

Iowa

consumer

fraud

Act,

2

unless

otherwise

stated

in

the

new

Code

section.

The

new

Code

3

section

specifies

particular

enforcement

actions

that

the

4

attorney

general

can

take

under

the

new

Code

section,

including

5

seeking

an

assessment

of

civil

fines

not

exceeding

$50,000

per

6

violation,

requesting

from

a

district

court

a

cease

and

desist

7

order

or

other

injunctive

relief

as

appropriate,

and

publicly

8

disclosing

violative

conduct

for

consumer

awareness.

For

the

9

purposes

of

the

new

Code

section,

each

day

of

any

continuing

10

violation

constitutes

a

separate

violation.

11

The

new

Code

section

provides

that

any

enforcement

action

12

taken

by

the

attorney

general

must

be

in

accordance

with

due

13

process

and

is

subject

to

appeal

to

the

Iowa

district

court.

14

The

attorney

general

may

adopt

rules

pursuant

to

Code

15

chapter

17A

as

necessary

or

appropriate

to

implement

the

new

16

Code

section.

17

The

bill

provides

that

any

moneys

collected,

including

18

civil

penalties,

costs,

attorney

fees,

or

amounts

which

are

19

specifically

directed

be

paid

into

to

the

consumer

protection

20

and

litigation

fund

established

in

Code

section

714.16C,

a

fund

21

administered

by

the

attorney

general

designated

for

consumer

22

litigation

and

education

purposes.

23

-4-

LSB

5037YH

(3)

91

ak/jh

4/

4